Estrogen-progestin replacement therapy and endometrial cancer.
about
Progestin effects on cell proliferation pathways in the postmenopausal mammary glandHormone therapy in postmenopausal women and risk of endometrial hyperplasiaHormone replacement therapy for women previously treated for endometrial cancerHormone therapy in postmenopausal women and risk of endometrial hyperplasiaOsteoclast differentiation factor RANKL controls development of progestin-driven mammary cancerCancer of the endometrium: current aspects of diagnostics and treatmentHormone replacement therapy for women previously treated for endometrial cancerIARC monographs program on carcinogenicity of combined hormonal contraceptives and menopausal therapyRANKL/RANK-beyond bonesPostmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective studyAssessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to AdalimumabLong-term postmenopausal hormone therapy and endometrial cancerAlcohol and breast cancer risk among Asian-American women in Los Angeles County.Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.The impact of estrogen replacement therapy and raloxifene on osteoporosis, cardiovascular disease, and gynecologic cancers.Hormone therapy, DNA methylation and colon cancer.Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.The LH/hCG Axis in Endometrial Cancer: A New Target in the Treatment of Recurrent or Metastatic Disease.Risks and benefits of hormone replacement therapy.Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy.Hormone replacement therapy and the endometrium.Menopausal hormone therapy and risk of endometrial cancer.Markers of inflammation and risk of ovarian cancer in Los Angeles CountyBirth weight and other prenatal factors and risk of breast cancer in Asian-Americans.Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives.Design and conduct of clinical trials in hormone replacement therapy.Cardioprotective benefits of hormone replacement therapy.Spontaneous regression of neoplasms: new possibilities for immunotherapy.The World Health Organization defines hormone replacement therapy as carcinogenic: is this plausible?Risk factors for ovarian cancer: an overview with emphasis on hormonal factors.Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.Molecular pathogenesis and prognostic factors in endometrial carcinoma.Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancerCalcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotypeVariations in sex hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancerEstablished risk factors account for most of the racial differences in cardiovascular disease mortality.African Americans and Hispanics Remain at Lower Risk of Ovarian Cancer Than Non-Hispanic Whites after Considering Nongenetic Risk Factors and Oophorectomy Rates.Prevention of cancers of the breast, endometrium and ovary.
P2860
Q21092903-DFB76961-4607-4433-BB98-84D43913D925Q24201543-4C151224-5CBE-4B0C-BC36-43F568F989C9Q24234201-7AF6F573-C4E8-46AA-BC9D-172C77F8BABBQ24241713-C6119401-D849-4FC0-A265-274131B4F9ABQ24605866-66068ACA-9849-4C1E-859A-858319B2AF00Q24797130-16A59F1D-8C55-4D1C-9EC2-FF9522B8A845Q26471218-2E02468F-0567-49D1-89C4-92BD7121F74BQ28194282-55B8C208-CA8A-4B60-921A-DE136DFC936DQ28308042-EFE9DECE-B0A2-4119-8869-AB6867F96664Q28361980-2466F2DF-E010-4CD0-903B-461D24CBE40BQ28831404-5409C874-EB7D-4201-ADFF-7750A9C6F30AQ33650188-313A8A92-9DA6-4E07-8892-0107DB15FDA4Q33739403-7FE13409-CE5D-41B0-ACAA-EF3E583CFEDFQ33765709-48DD2C62-BF12-4B39-BED7-2C21045784E6Q33814554-B122A992-B716-4211-981D-3052EA963061Q33884570-C6D1F671-F521-46F2-83F7-CECB0CB679F1Q33899430-16CEE1AA-80A3-428B-8330-35422FCA8A62Q34035556-491AA0E6-3C64-4F1C-AED1-88C3BD8C7074Q34039811-AD3CC8F2-2BBA-4046-B58B-C24DF8C50055Q34042346-9471A37A-F5F7-4AF3-8939-391CC265E626Q34145853-005AC536-F093-4703-99C6-291C81B6B082Q34227082-82BBEC85-C95B-4DA7-AB7E-D4E8C41CDC86Q34263283-00204A97-FC6E-4E0F-AC87-A7CAC2576AE2Q34345110-8F80C5DF-7401-4A59-9AF9-AEDC4AE17719Q34372351-89E03D41-E718-4791-8EA2-4F3B35762F47Q34372879-4063FE35-E4C4-44BB-90A2-755E0AEF68E0Q34397284-3E93122A-BC0C-4B87-A7EA-2188BFBF7997Q34397332-588C01DA-BB4C-4F9A-A769-658E60FF8C70Q34585847-9F4B8051-53DA-41B2-84D9-FC3BD4F6B842Q34701352-1B4B88F2-457F-4B1C-8E3C-BAD1749543A2Q34760979-E22698B1-E3F6-4886-A62E-AFE7A20920D2Q34764768-748B8C57-9136-409C-98C5-940E06AD1D33Q35006892-BD44C9C8-8F3C-4C6D-869E-DF6A989725EBQ35065032-75342885-F13E-47EC-A052-225ACC70F25CQ35510465-94AE4E62-B0CD-4C74-AB28-71095756DB35Q35603160-190F139E-8D27-445B-9E01-5369B6F2C952Q35705758-C5772908-F10E-4AD3-B988-9D28301789BEQ35741878-7078EAE1-B719-4AFD-97BC-D595A296C407Q35815569-BE3E8BB3-1D17-4407-81F5-C671A7FB8B1BQ35868030-957C7630-8888-468A-8F56-A706E108370B
P2860
Estrogen-progestin replacement therapy and endometrial cancer.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Estrogen-progestin replacement therapy and endometrial cancer.
@en
type
label
Estrogen-progestin replacement therapy and endometrial cancer.
@en
prefLabel
Estrogen-progestin replacement therapy and endometrial cancer.
@en
P2093
P2860
P356
P1476
Estrogen-progestin replacement therapy and endometrial cancer.
@en
P2093
Probst-Hensch NM
P2860
P304
P356
10.1093/JNCI/89.15.1110
P407
P577
1997-08-01T00:00:00Z